Furthermore, we examined the expression levels of the PHF10 gene on the basis of various clinicopathological characteristics of GC patients, including Normal (n = 34) and different stages: stage 1 (n = 34), stage 2 (n = 123), stage 3 (n = 169), and stage 4 (n = 41), gender: Males (n = 268) and Females (n = 147), age: 21–40 years (n = 4), 41- 60 years (n = 128), 61–80 years (n = 253) and 81–100 years (n = 25). This evidence concerns the gene PHF10 and gastric cancer.